MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$34,950K
Proceeds from stock
options exercised
$651K
Net cash provided by
investing activities
$34,802K
Net cash provided by
financing activities
$484K
Effect of exchange rate
changes on cash, cash...
$24K
Canceled cashflow
$148K
Canceled cashflow
$167K
Decrease in cash, cash
equivalents and restricted...
-$5,725K
Canceled cashflow
$35,310K
Stock-based compensation
expense
$2,587K
Depreciation and
amortization
$1,171K
Non-cash rent expense
$879K
Accounts payable
$484K
Change in fair value of
contingent consideration...
$109K
Prepaid expenses and
other current assets
-$3K
Purchases of property and
equipment
$148K
Payment of deferred
offering costs
$143K
Principal payments on
finance leases
$24K
Net cash used in
operating activities
-$41,035K
Canceled cashflow
$5,233K
Net loss
-$38,262K
Accrued expenses and
other current...
-$4,766K
Other non-current
assets
$1,686K
Lease liabilities
-$1,225K
Accretion of discount on
marketable securities
$296K
Loss (gain) from
disposal of property and...
$33K
Back
Back
Cash Flow
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. (ODTX)
source: myfinsight.com